Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,764 | 191 | 99.3% |
| Education | $20.00 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $521.75 | 43 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $327.78 | 19 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $320.26 | 23 | $0 (2023) |
| ITI, Inc. | $254.61 | 26 | $0 (2023) |
| Novo Nordisk Inc | $251.28 | 16 | $0 (2022) |
| Indivior Inc. | $138.87 | 7 | $0 (2024) |
| Avanir Pharmaceuticals, Inc. | $120.89 | 7 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $111.28 | 7 | $0 (2022) |
| Alkermes, Inc. | $91.56 | 4 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $90.21 | 5 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $560.50 | 33 | ABBVIE INC. ($219.95) |
| 2023 | $587.62 | 41 | Otsuka America Pharmaceutical, Inc. ($177.49) |
| 2022 | $811.40 | 60 | ITI, Inc. ($186.47) |
| 2021 | $824.30 | 58 | Novo Nordisk Inc ($187.25) |
All Payment Transactions
192 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: Neuropsychiatry | ||||||
| 12/02/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: OUD | ||||||
| 11/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.69 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.76 | General |
| 10/31/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: PSYCHIATRY | ||||||
| 10/29/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Neuropsychiatry | ||||||
| 10/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.72 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.60 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: NEUROSCIENCE | ||||||
| 09/10/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: OUD | ||||||
| 09/09/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.36 | General |
| 08/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: NEUROSCIENCE | ||||||
| 08/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: NEUROSCIENCE | ||||||
| 08/13/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: PSYCHIATRY | ||||||
| 08/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.67 | General |
| Category: NEUROSCIENCE | ||||||
| 08/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $1.54 | General |
| Category: NEUROSCIENCE | ||||||
| 07/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: NEUROSCIENCE | ||||||
| 07/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: NEUROSCIENCE | ||||||
| 06/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: NEUROSCIENCE | ||||||
| 06/17/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: OUD | ||||||
| 06/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.80 | General |
| Category: NEUROSCIENCE | ||||||
| 06/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.80 | General |
| Category: NEUROSCIENCE | ||||||
| 05/23/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $28.12 | General |
| Category: PSYCHIATRY | ||||||
| 05/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 57 | 103 | $10,300 | $4,742 |
| 2022 | 1 | 24 | 31 | $3,100 | $1,576 |
All Medicare Procedures & Services
2 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 57 | 103 | $10,300 | $4,742 | 46.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 24 | 31 | $3,100 | $1,576 | 50.8% |
About Mary Long, FNP-BC
Mary Long, FNP-BC is a Family healthcare provider based in Low Moor, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/29/2019. The National Provider Identifier (NPI) number assigned to this provider is 1659939387.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Mary Long, FNP-BC has received a total of $2,784 in payments from pharmaceutical and medical device companies, with $560.50 received in 2024. These payments were reported across 192 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($2,764).
As a Medicare-enrolled provider, Long has provided services to 81 Medicare beneficiaries, totaling 134 services with total Medicare billing of $6,318. Data is available for 2 years (2022–2023), covering 2 distinct procedure/service records.
Practice Information
- Specialty Family
- Other Specialties Family
- Location Low Moor, VA
- Active Since 05/29/2019
- Last Updated 05/29/2019
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1659939387
Products in Payments
- VRAYLAR (Drug) $421.92
- CAPLYTA (Drug) $286.56
- Ozempic (Drug) $169.67
- REXULTI (Drug) $155.83
- XARELTO (Drug) $130.11
- Nuedexta (Drug) $120.89
- INVEGA SUSTENNA (Drug) $101.04
- SUBLOCADE (Drug) $100.23
- NUEDEXTA (Drug) $90.68
- UBRELVY (Drug) $86.58
- ARISTADA (Drug) $71.56
- INVOKANA (Drug) $69.05
- ABILIFY MAINTENA (Drug) $68.85
- Vascepa (Drug) $67.89
- TRINTELLIX (Drug) $67.71
- JARDIANCE (Drug) $63.36
- TRELEGY ELLIPTA (Drug) $59.74
- TRULICITY (Drug) $45.73
- VYVANSE (Drug) $43.57
- ABILIFY ASIMTUFII (Drug) $40.54
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.